CD8<sup>+</sup><i>γδ</i> T Cells Are More Frequent in CMV Seropositive Bone Marrow Grafts and Display Phenotype of an Adaptive Immune Response

Gaballa, Ahmed; Arruda, Lucas C. M.; Rådestad, Emelie; Uhlin, Michael

doi:https://doi.org/10.1155/2019/6348060

Stem Cells International

On this page

Abstract Introduction Methods Results Discussion Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments Supplementary Materials References Copyright Related Articles

Special Issue

Infections in Hematopoietic Stem Cell Transplant

View this Special Issue

Research Article | Open Access

Volume 2019 | Article ID 6348060 | https://doi.org/10.1155/2019/6348060

CD8⁺γδ T Cells Are More Frequent in CMV Seropositive Bone Marrow Grafts and Display Phenotype of an Adaptive Immune Response

Ahmed Gaballa,¹Lucas C. M. Arruda,¹Emelie Rådestad,¹and Michael Uhlin^1,2,3

Guest Editor: Tahir Shamsi

Received23 Apr 2019

Revised24 Oct 2019

Accepted20 Nov 2019

Published06 Dec 2019

Abstract

The role of gamma delta (γδ) T cells in human cytomegalovirus (HCMV) immune surveillance has been the focus of research interest for years. Recent reports have shown a substantial clonal proliferation of γδ T cells in response to HCMV, shedding light on the adaptive immune response of γδ T cells. Nevertheless, most efforts have focused on Vδ2^negγδ T cell subset while less attention has been given to investigate other less common γδ T cell subsets. In this regard, a distinct subpopulation of γδ T cells that expresses the CD8 coreceptor (CD8⁺γδ T cells) has not been thoroughly explored. Whether it is implicated in HCMV response and its ability to generate adaptive response has not been thoroughly investigated. In this study, we combined flow cytometry and immune sequencing of the TCR γ-chain (TRG) to analyze in-depth bone marrow (BM) graft γδ T cells from CMV seropositive (CMV+) and CMV seronegative (CMV-) donors. We showed that the frequency of CD8⁺γδ T cells was significantly higher in CMV+ grafts compared to CMV- grafts (). Further characterization revealed that CD8⁺γδ T cells from CMV+ grafts express Vγ9^- and preferentially differentiated from a naive to terminal effector memory phenotype (CD27^low/-CD45RO^-). In line with these findings, TRG immune sequencing revealed clonal focusing and reduced usage of the Vγ9/JP gene segment in a CMV+ graft. Furthermore, CD8⁺γδ T cells showed an enhanced response to TCR/CD3 and cytokine stimulation in contrast to CD8^-γδ T cells. We conclude that γδ T cells in BM grafts are reshaped by donor CMV serostatus and highlight the potential adaptive role of CD8⁺γδ T cells in HCMV immune response.

1. Introduction

Human cytomegalovirus (HCMV) is a DNA virus that belongs to the β-herpes virus family [1]. In immunocompetent individuals, HCMV establishes a lifelong latent infection that is usually asymptomatic. However, in conditions where the immune system is dampened, such following allogeneic Hematopoietic Cell Transplantation (HCT), HCMV can be life-threatening, rendering CMV infection/reactivation a major cause of morbidity and mortality after HCT [2].

Human γδ T cells are unconventional T cells that express a T cell antigen receptor (TCR) formed by γ and δ chains and fundamentally differ from αβ T cells in their major histocompatibility complex- (MHC-) independent antigen recognition [3]. In allogeneic HCT, γδ T cell reconstitution occurs shortly after transplantation [4], a process that has been associated with a favorable outcome, indicating their crucial role in protection against tumors and pathogens [5–7].

The role of γδ T cells in HCMV immune surveillance has been shown previously [8]. However, the underlying immune mechanism and the ligand/s mediating γδ T cell activation are poorly understood [8, 9]. Furthermore, whether γδ T cells respond to HCMV through innate or adaptive immune pathways is unclear. Vγ9⁺Vδ2⁺ cells express a semi-invariant TCR and respond to a limited range of nonpeptide antigens such as phosphoantigens, rendering their response innate-like in nature. In contrast, Vδ2^negγδ T cells have a wider range of ligands and display high diverse TCR repertoire at birth that become focused at adulthood, sharing more properties of adaptive immunity [10, 11].

HCMV infection is associated with a remarkable proliferation of Vδ2^negγδ subsets, particularly Vδ1⁺ cells [1]. Recently, next-generation sequencing of the TCR chains δ (TRD) and γ (TRG) has allowed an in-depth analysis of the γδ TCR repertoire reshaping in response to HCMV. Using this state-of-the-art technique, Ravens et al. and Davey et al. have revealed for the first time CMV-associated clonotypic changes in the γδ TCR repertoire [12–14]; their reports provide strong evidence for the ability of γδ T cells to mount a virus-specific nonconventional adaptive immune response.

The majority of human adults circulating γδ T cells are double negative for CD8 and CD4 coreceptors (CD4^- CD8^-), partially accounting for their MHC independence [13]. However, a small subpopulation of γδ T cells expresses the CD8 coreceptor (CD8⁺γδ T cells). Reports from several research groups including ours suggested distinct immunobiology of this subset [15, 16]. In the context of allogenic HCT, the role of this subset in HCMV infection has not yet been fully described. Whether CD8⁺γδ T cells undergo clonal proliferation in response to HCMV and if they are capable of mounting adaptive function has so far not been shown. It is therefore fundamental to address their potential role in CMV immune response. In this study, we characterized γδ T cells in BM grafts from CMV+ and CMV- donors using multicolor flow cytometry in addition to immune sequencing of the TCR γ chain (TRG).

2. Subjects and Methods

2.1. Donor Characteristics and Ethical Approval

A total of 16 samples (13 males and 3 females) were obtained from BM grafts before allogeneic HCT at the Cell Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital, Sweden. Out of 16 donors, 7 were CMV seropositive (CMV+) and 9 were CMV seronegative (CMV-). The median age of the donors was 28 and 22 years for CMV+ and CMV- donors, respectively. Written informed consent for sample collection and subsequent analysis was provided. The study was approved by the regional ethical review board in Stockholm (2008/206-31, 2010/760-31/1, 2013/2215-32, and 2017/469-32).

2.2. Sample Preparation

Mononuclear cells (MNC) were freshly isolated from BM grafts by density gradient centrifugation (Lymphoprep, Fresenius Kabi, Oslo, Norway) as described previously [17], were cryopreserved in RPMI-1640 media containing 10% DMSO and supplemented with 10% human AB serum, and were stored in liquid nitrogen freezer until time of analysis.

2.3. Multicolor Flow Cytometry

Cryopreserved samples were thawed, washed, and resuspended in PBS. Surface staining was performed according to standard protocols as published before [18]. Immunophenotyping was performed using fluorochrome-conjugated anti-human monoclonal antibodies (mAb) as follows: CD3-BV450 (UCHT1), CD3-BV510 (UCHT1), CD4-Alexa Fluor 700 (RPA-T4), CD8-APC-Cy7 (SK1), CD27-BV421 (M-T271), CD45RO-APC (UCHL1), CD197 (CCR-7)-PE-Cy7 (3D12), and CD69-FITC (L78) (BD Biosciences); CD158b-PE-Cy7 (DX27) and TCR Vγ9-FITC (B3) (BioLegend); TCR Vδ1-FITC (TS8.2) (Thermo Scientific); and TCR pan γδ-PE (REA591) and TIM3-APC (F38-2E2) (Miltenyi Biotec). FACS CANTO (BD Biosciences, San Jose, CA, USA) was used to acquire samples, and FlowJo V10 (TreeStar) was used to analyze the results. The gating strategy is shown in Figure 1(a).

(a)

(b)

(c)

Manual gating was used to characterize individual samples, and subsequently, data were downsampled and merged (concatenated) for further visualization using dimensionality reduction algorithm plugin, t-Distributed Stochastic Neighbor Embedding (tSNE).

2.4. γδ Genomic DNA Extraction and Immunosequencing

MNCs from one CMV+ and one CMV- BM grafts were thawed, γδ T cells were sorted using the TCR γ/δ T cell isolation kit (Miltenyi Biotec) according to the manufacturer’s protocol, and γδ purity was confirmed by FACS. Next, genomic DNA was extracted using the EZ1® DNA Blood Kit and EZ1 instruments (Qiagen, Germany) according to the manufacturer’s instructions. Concentration and purity of eluted DNA were analyzed using NanoDrop 2000 (Thermo Fisher Scientific), and DNA samples were stored at -20°C. An average of 1 μg of genomic DNA was used for high throughput sequencing of the CDR3 region of TRG using the ImmunoSEQ platform (Adaptive Biotechnologies, Seattle, WA) as described previously [19]. Briefly, amplification of V-J segments was performed in a bias-controlled multiplex PCR reaction using primers specific for Vγ and Jγ gene segments. A specific algorithm was then applied to correct for sequencing error. CDR3 segments were annotated according to the International ImmunoGeneTics collaboration.

2.5. TCR γδ CDR3 Spectratyping

CD8⁺ and CD8^-γδ T cells were sorted from CMV+ grafts on a cell sorter (Sony MA900, Sony Biotechnology Inc.). RNA was extracted (AllPrep DNA/RNA Mini Kit, Qiagen, Germany) and immediately converted to cDNA (SuperScript™ IV VILO™ Master Mix, Thermo Fisher Scientific) as previously described [17]. The CDR3 region for Vγ2, Vγ3, Vγ4, Vγ5, Vγ9, and Vδ1 was amplified by PCR using forward primers specific for each V gene segment and a common 5FAM-labeled reverse primer for the constant γ (Cγ) or δ (Cδ) genes as described elsewhere [20] (Table S1). PCR conditions and spectratyping were performed according to a protocol described in detail previously [16].

2.6. T Cell Culture and Proliferation Assays

CD3⁺ T cells from donor BM grafts were magnetically bead sorted (Pan T Cell Isolation Kit, Miltenyi Biotec) and labeled using CellTrace violet (Thermo Fisher Scientific) according to the manufacturer’s instructions. Labeled T cells were cultured in a 96-well plate ( cells/mL) in a complete RPMI-1640 medium (containing 10% human AB serum, 50 μg/mL penicillin/streptomycin) either alone (unstimulated) or in the presence of anti-CD3 (clone OKT3, BioLegend), IL-7, IL-15, or IL-18 at 30 ng/mL (PeproTech) and were incubated at 37°C and 5% CO₂ for 5 or 7 days (for anti-CD3 or cytokines, respectively). Cells were analyzed by FACS, and proliferating cells were defined as % of CellTrace violet (CTV) low cells compared to unstimulated conditions. In addition to proliferation assay, staining for activation/exhaustion surface markers (CD69, TIM3, and KIR2DL2/3) was performed.

2.7. Bioinformatics and Statistics

Parametric test statistics were used throughout the study after confirming that assumptions of normality were not violated using the Shapiro test and Q-Q plots. When comparing two groups, the Student -test or paired -test was used as indicated. ANOVA followed by post hoc multiple comparisons (Tukey’s correction) were used when three or more unrelated groups were compared, and repeated measures ANOVA when the compared groups were related (paired). A value < 0.05 was considered statistically significant, and the following significance levels were used: , , and . GraphPad Prism version 6.00 for Windows (GraphPad Software, La Jolla, California, USA) and IBM SPSS Statistics for Windows, Version 24.0. (Armonk, NY: IBM Corp.) were used to perform statistics. The ImmunoSEQ tool was used for initial handling of sequencing data, and diversity, clonal space homeostasis, V-J segment usage, CDR3 spectratyping, and repertoire overlap were performed using specific packages as previously described [19].

3. Results

3.1. Characterization of γδ T Cell Subsets in BM Grafts

To address whether γδ T cell proportions in BM grafts are influenced by donor CMV serostatus, we characterized γδ T cells from CMV+ () and CMV- () BM grafts using a multicolor flow cytometer (Figure 1(a)). Immunophenotyping results showed no significant difference in the frequency of total γδ T cells between CMV+ and CMV- grafts (data not shown). However, further analysis of γδ T cell subsets revealed increased proportions of Vδ1⁺ and Vγ9^- subsets in CMV+ compared to CMV- BM grafts ( vs. 16.3%, and 57.6% vs. 38.3%, , respectively) (Figure 1(b)). Strikingly, the frequency of CD8⁺γδ T cells was significantly higher in CMV+ grafts as compared to CMV- grafts ( vs. 10.7%, ).

To gain more insight, we used a dimensionality reduction algorithm (tSNE) to visualize clusters of Vγ9⁺ and Vγ9^- subpopulations from CMV+ and CMV- grafts. Vγ9^- subset represented a predominant distinct cluster of γδ T cells within CMV+ grafts compared to CMV- grafts (Figure 1(c)). Furthermore, tSNE-generated histograms from Vγ9^- and Vγ9⁺ subpopulations showed remarkable downregulation of CD45RO in Vγ9^- subpopulation when compared to Vγ9⁺ both in CMV+ and in CMV- grafts. Additionally, CD27 downregulation was more prominent in Vγ9^- subpopulation in CMV+ grafts (Figure 1(c)).

3.2. Vγ9^- Subsets within CMV+ Grafts Are Differentiated towards a Terminal Effector Phenotype

The ability to differentiate from naïve to a memory phenotype is a characteristic of the adaptive immunity. To address this, we analyzed the frequency of naive CD27⁺CD45RO^-, central memory (CM) CD27⁺CD45RO⁺, effector memory (EM) CD27^low/-CD45RO⁺, and terminal effector (TE) CD27^low/-CD45RO^- phenotypes among Vγ9 subsets in CMV+ and CMV- grafts (Figures 2(a) and 2(b)). Proportions of CD27^low/-CD45RO^- (TE) Vγ9^-γδ T cells were markedly increased in CMV+ grafts, whereas no difference was found in CMV- grafts (Figure 2(b)). Additionally, Vγ9^-γδ T cells from CMV+ grafts displayed a higher frequency of effector phenotype, CD27^low/-CD45RO^-/+ (combined EM and TE) γδ T cells (Figure 2(c)), and lower frequency of naïve phenotype though it did not reach the significant level (Figure 2(d)).

(a)

(b)

(c)

(d)

Figure 2

Vγ9^- subsets within CMV+ grafts are enriched with an effector phenotype. (a) A representative FACS plot showing memory phenotype in Vγ9^- subsets of CMV- and CMV+ grafts. (b) Proportions of naïve (CD27⁺CD45RO^-), CM (CD27⁺CD45RO⁺), EM (CD27low/^-CD45RO⁺), TE (CD27low/^-CD45RO^-) γδ T cells among Vγ9^- subset of CMV- grafts and CMV+ grafts. Repeated measures ANOVA is used. Proportions of effector (CD27low/^-CD45RO^-/⁺) γδ T cells (c) and naïve γδ T cells (d) in Vγ9^- and Vγ9⁺ subsets in CMV+ and CMV- grafts. ANOVA is used. Bar and whiskers represent the mean and S.E.M.

3.3. CD8⁺γδ T Cells within CMV+ BM Grafts Express Vγ9^- and Preferentially Display Effector Phenotype

As CMV+ grafts showed significantly increased proportions of CD8⁺γδ T cells, we sought to further characterize this subset. Interestingly, comparison between CD8⁺ and CD8^-γδ T cells revealed increased proportions of Vγ9^- in CD8⁺γδ T cells from CMV+ grafts compared to both CD8⁺ and CD8^-γδ T cells from CMV- grafts (Figure S1A).

Next, we investigated whether the increased frequency of CD8⁺γδ T cells is linked to differentiation. Comparing the frequency of different memory phenotypes revealed increased proportions of CD27^low/-CD45RO^- (TE) γδ T cells among CD8⁺γδ T cells only in CMV+ grafts (Figures 3(a) and 3(b)). Importantly, the frequency of combined EM and TE phenotypes (CD27^low/-CD45RO^-/⁺) was higher among CD8⁺γδ T cells from CMV+ grafts as compared to either CD8⁺ or CD8^-γδ T cells from CMV- grafts (Figure 3(c)). Consistently, CD8⁺γδ T cells from CMV+ grafts showed decreased proportions of naïve γδ T cells compared to CD8⁺ or CD8^-γδ T cells from CMV- grafts (Figure 3(d)). In line with this memory phenotype, γδ T cells from CMV- grafts tend to express more CCR7⁺ when compared to CMV+ grafts (Figure S1B).

(a)

(b)

(c)

(d)

3.4. γδ TRG Repertoire is Clonally Focused in CMV+ Grafts

As flow cytometry data indicated a CMV-driven proliferation of CD8⁺γδ T cells that displayed effector phenotype and preferentially enriched with Vγ9^-γδ T cells, we, therefore, sought to characterize the TRG CDR3 clonotypes of γδ T cells to determine if there are differences regarding TCR diversity or clonal focusing driven by CMV infection. The CMV+ graft displayed several single clone expansions, as depicted by treemap (Figure 4(a)) and quantile plots (Figure 4(b)). Consequently, the TCR diversity was consistently lower in the CMV+ graft when compared to the CMV-, including inverse Simpson’s D (85.19 vs. 302.50), Efron-Thisted estimator (5347.45 vs 57100.37), and iChao1 estimate (3090.92 versus 51054.66). Additionally, the CMV+ graft presented reduced singleton frequency (clones met once in the repertoire, 0.51% versus 39.00%, Figure 4(b)), high space taken by the top 10 most abundant clones (31.72% versus 11.34%, Figures 4(b) and 4(c)), high frequency of hyperexpanded clones (30.85% vs. 8.38%, Figure 4(d)), and high clonality (0.30 vs. 0.15), altogether demonstrating a high clonal focusing in this sample.

(a)

(b)

(c)

(d)

Figure 4

CMV+ BM grafts present less TRG diversity and high clonality. (a) Tree plots showing a CMV- and CMV+ BM graft donor TRG repertoire. Each CDR3 clonotype is colored accordingly to its amino acid sequence and is sized in relation to its repertoire frequency (the colors were chosen randomly and does not match between plots). (b) Quantile plots of a CMV- and CMV+ BM graft depicting the top 10 most frequent clonotypes. The pie chart is divided into singletons (clonotypes represented by a single read), doubletons (two reads), and high-order clonotypes (three and more reads). High-order clonotypes are divided into five quantiles (top 20% of unique high-order clonotypes and so on). The size of each segment is the cumulative frequency of all clonotypes that fall into the corresponding frequency category. (c) The clonal proportion of the top clonotypes. Red bars represent the TRG proportion taken by the 10 most abundant clones shown in (b). (d) Proportion of homeostatic space occupied by clonotypes classified as hyperexpanded (0.01–1), large (0.001–0.01), medium (0.0001–0.001), small (0.00001–0.0001), and rare (0–0.00001).

Consistent with our previous work [19], the CMV- graft presented a high proportion of clones with a TRG consisting of 14 amino acids (59.44% vs. 24.81% in the CMV+ graft). In contrast, the CMV+ graft presented an enrichment of clones with a TRG length of 7 to 12 amino acids and a reduced frequency of those with 14 to 16 amino acid length (Figure 5(a)). These changes resulted in the shift from a Gaussian-distributed spectratype observed in the CMV- graft to a skewed repertoire in the CMV+ graft (Figure 5(b)). Furthermore, by evaluating the V-J pairing, we found that Vγ9/JP segments were the most commonly used segments in the CMV- graft. In the CMV+ graft, the Vγ3/J2, Vγ4/J2, Vγ5/J2, Vγ8/J2, and Vγ9/J2 were more used, while the Vγ9-JP pair was dramatically reduced (Figures 5(c) and 5(d)).

(a)

(b)

(c)

(d)

Figure 5

CMV positivity is associated with TRG reshaping and V-J segment usage changes. (a) TRG spectratype. Bars represent the frequency of unique CDR3 sequences with different amino acid lengths in a CMV+ and CMV- graft donor. (b) The distribution pattern of the clonotypes shown in (a). Lines represent the nonlinear curve fitting (Gauss function) in each donor. The vertical line indicates the median length in each donor. (c) V-J segment pairing abundance in CDR3 junctions of each donor based on CMV status. Chord diagrams are used for visualization. Ribbons connecting segment pairs are scaled by corresponding V-J pair frequency. (d) The frequency of different TRGV-TRGJ rearrangements shown in (c). Bars represent the usage of a given V-J junction in each graft.

As NGS data showed clonal focusing in CMV+ grafts, we hypothesized that CD8⁺γδ T cells are more clonally focused. To investigate this further, we assessed the TCR repertoire in sorted CD8⁺ and CD8^-γδ T cells by CDR3 spectratyping. Analysis of two CMV+ grafts revealed a more focused TCR repertoire in CD8⁺γδ T cells compared to CD8^-γδ T cells (Figure S2).

3.5. TCR/CD3 Stimulation Triggers CD8⁺γδ T Cells

As our results suggested an adaptive-like phenotype of CD8⁺γδ T cells, we sought to alleviate the potential role of TCR in the activation and proliferation of CD8⁺γδ T cells. TCR/CD3 stimulation resulted in significantly increased proliferation of CD8⁺γδ T cells compared to CD8^-γδ T cells (Figures 6(a) and 6(b)). Furthermore, this TCR-driven proliferation was accompanied by increased frequencies of CD69⁺, TIM3+, and KIR2DL2/L3+ γδ T cells in CD8⁺γδ T cells compared to CD8^-γδ T cells (Figure 6(c) and 6(d)) indicating their activation.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

Figure 6

Enhanced response of CD8⁺γδ T cells to TCR and cytokine stimulation. (a) representative histograms () of proliferating T cells from unstimulated or TCR/CD3 stimulated condition, gated on TCR γδ^- CD8⁺ (blue), CD8⁺γδ (green), and CD8^-γδ (orange). (b) Proportions of proliferating CD8⁺γδ (green) and CD8^-γδ (orange) cells after TCR/CD3 stimulation. (c) Representative FACS plot of TIM3, CD69, and KIR2DL2/L3 gated on CD8⁺γδ (upper) and CD8^-γδ (lower) T cells after TCR/CD3 stimulation. (d) Proportions of CD8⁺γδ T cells (blue) and CD8^-γδ T cells (red) expressing TIM3+, CD69+, and KIR2DL2/L3+ after TCR/CD3 stimulation. Paired -test used. (e) Representative histogram of proliferation of CD8⁺γδ (A) and CD8^-γδ (B) cultured in the presence of medium only (green), IL-7 (orange), IL-15 (blue), and IL-18 (red). Proportions of proliferating cells after culture in a medium, IL-7, IL-15, and IL-18 in CD8⁺γδ (f) and CD8^-γδ (g). Repeated measures ANOVA is used. Bar and whiskers represent the mean and S.E.M.

3.6. γδ T Cell Proliferation in response to Cytokine Stimulation

Next, we tested the impact of different cytokines on γδ T cell proliferation (Figure 6(e)). Interestingly, we observed a remarkably increased proliferation of CD8⁺γδ T cells in response to IL-7 and IL-15 but not to IL-18. In contrast, there was no significant difference in the proliferation of CD8^-γδ T cells upon stimulation with IL-7, IL-15, or IL-18 (Figures 6(e)–6(g)).

4. Discussion

Consistent with previous reports, we showed higher proportions of Vδ1⁺γδ T cells in CMV+ grafts. In fact, it has been shown that Vδ1⁺γδ subset can pair to any Vγ chains including Vγ9 [13]. Of note, FACS data alone cannot show whether Vδ1 couple to the semi-invariant or the noninvariant Vγ9 chain. Using NGS, we showed less prevalence of JγP-Vγ9 pairing in CMV+ grafts [19]. In their study, Vermijlen et al. showed that CMV-responsive γδ T cells were restricted to Vγ9^- subset, irrespective of the Vδ chain usage [21]. Furthermore, a recent study showed that a distinct subset of Vδ2⁺γδ T cells expresses Vγ9^- (Vγ9^-Vδ2⁺) and displayed an adaptive-like phenotype [22]. Therefore, Vγ9^- subset of γδ T cells can better represent the adaptive-like compartment of γδ T cells compared to Vδ2^neg subset. In this context, our results showed an increased frequency of Vγ9^-γδ T cells in BM grafts from CMV+ compared to CMV- donors () and were preferentially differentiated to TE phenotype (CD27^low/-CD45RO^-) supporting an adaptive role of Vγ9^-γδ T cells.

γδ T cells expressing the CD8 coreceptor represent an unusual subpopulation of γδ T cells. Compared to the more common CD4^-CD8^-γδ T cells, their development and function are poorly understood. Reports have shown that CD8⁺γδ T cells selectively localize to intestinal epithelial tissue and are mostly Vδ1⁺ [23, 24]. Furthermore, a potential role in intestinal inflammatory diseases has been recently described [15]. In line with previous report, we showed that CD8⁺γδ T cells are more frequent in CMV+ grafts [25] and express Vγ9^-γδ T cells. This CMV-driven proliferation was accompanied by a remarkable transition from CD27⁺ to CD27^low/- phenotype, indicating differentiation from naïve towards effector phenotype. Consistently, lymphoid homing receptor CCR7 in CD8⁺γδ T cells from CMV- grafts was higher as compared to CMV+ grafts, inferring their potential for homing to secondary lymphoid tissues and supporting a naïve phenotype in CMV- grafts. Whether this entails their ability to be primed by antigen-presenting cells in an adaptive-like manner remains to be investigated.

Importantly, it has been reported that CD8 coreceptors expressed by γδ T cells are mostly CD8αα, in contrast to CD8αβ expressed by conventional T cells [25]. In this regard, our study is limited as we have not assessed whether CD8αα or CD8αβ was mainly expressed; given the recent evidence on CD8αβ⁺γδ T cells [15], further characterization will be required to alleviate the immunobiological role of the different CD8 molecules.

We showed in a recent study that CD8⁺γδ T cells, in contrast to CD8^-γδ T cells, displayed higher proliferation and activation markers in response to allogeneic stimulation [16]. Furthermore, their proportions in stem cell grafts were associated with the incidence of acute graft-versus-host disease (GVHD), supporting potential alloreactivity [16]. In the present study, we extended our findings by showing that CD8⁺γδ T cells were more responsive to TCR stimulation (Figure 6) and their response pattern to cytokines was different from CD8^-γδ T cells, suggesting adaptive rather than innate response. Of note, the relationship between CMV reactivation and GVHD development after HCT is complex and can be bidirectional [26]. In light of our findings with regard to CD8⁺γδ T cells in stem cell grafts, it is valid to address whether CMV immune response and alloreactivity represent the dual face of this subset.

Consistent with previous reports, NGS results indicated repertoire perturbation in the form of TRG clonal focusing and higher usage of non-Vγ9 gene segments in γδ T cells from the CMV+ graft. Of note, CMV+ grafts were enriched with CD8⁺γδ T cells that strongly displayed a terminal effector memory phenotype, indicating that clonal focusing revealed by NGS represents the clonal proliferation of CD8⁺γδ T cells. Though we have demonstrated in small scale spectratype that TCR repertoire was more clonally focused in CD8⁺γδ T cells, our study is limited as NGS analysis was not done on sorted CD8⁺γδ T cells to confirm this.

In conclusion, we showed that γδ T cell repertoire within BM grafts is reshaped by donor CMV serostatus and has provided evidence for the implication of CD8⁺γδ T cells in the HCMV immune response. Further studies are required to confirm our findings and to in-depth alleviate the impact of CMV-induced TCR repertoire and phenotypic changes of CD8⁺γδ T cells.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Authors’ Contributions

Ahmed Gaballa and Lucas C. M. Arruda contributed equally to the study.

Acknowledgments

This study was supported by the Stockholm County Council, Swedish Research Council, Children Cancer Foundation, and Radiumhemmets Forskningsfonder.

Supplementary Materials

Table S1: sequences of primers used for spectratyping. Vγ = variable gamma; Cγ = constant gamma; Cδ = constant delta. (Supplementary Materials)

References

V. Pitard, D. Roumanes, X. Lafarge et al., “Long-term expansion of effector/memory Vδ2⁻γδ T cells is a specific blood signature of CMV infection,” Blood, vol. 112, no. 4, pp. 1317–1324, 2008.
View at: Publisher Site | Google Scholar
J. Inagaki, M. Noguchi, K. Kurauchi, S. Tanioka, R. Fukano, and J. Okamura, “Effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia,” Biology of Blood and Marrow Transplantation, vol. 22, no. 2, pp. 300–306, 2016.
View at: Publisher Site | Google Scholar
A. H. Hovav, “Human γδ T cells: rapid, stable and clonally reactive,” Cellular & Molecular Immunology, vol. 14, no. 8, pp. 646–648, 2017.
View at: Publisher Site | Google Scholar
M. A. de Witte, D. Sarhan, Z. Davis et al., “Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy,” Biology of Blood and Marrow Transplantation, vol. 24, no. 6, pp. 1152–1162, 2018.
View at: Publisher Site | Google Scholar
L. S. Lamb Jr., P. J. Henslee-Downey, R. S. Parrish et al., “Rapid communication: Increased frequency of TCRγδ+ T cells in disease-free survivors following T cell-depleted, partially mismatched, related donor bone marrow transplantation for leukemia,” Journal of Hematotherapy, vol. 5, no. 5, pp. 503–509, 1996.
View at: Publisher Site | Google Scholar
L. S. Lamb Jr., P. Musk, Z. Ye et al., “Human γδ⁺ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response,” Bone Marrow Transplantation, vol. 27, no. 6, pp. 601–606, 2001.
View at: Publisher Site | Google Scholar
R. Perko, G. Kang, A. Sunkara, W. Leung, P. G. Thomas, and M. H. Dallas, “Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia,” Biology of Blood and Marrow Transplantation, vol. 21, no. 1, pp. 130–136, 2015.
View at: Publisher Site | Google Scholar
J. Déchanet, P. Merville, A. Lim et al., “Implication of γδ T cells in the human immune response to cytomegalovirus,” The Journal of Clinical Investigation, vol. 103, no. 10, pp. 1437–1449, 1999.
View at: Publisher Site | Google Scholar
X. Lafarge, P. Merville, M.-C. Cazin et al., “Cytomegalovirus infection in transplant recipients resolves when circulating γδ T lymphocytes expand, suggesting a protective antiviral role,” The Journal of Infectious Diseases, vol. 184, no. 5, pp. 533–541, 2001.
View at: Publisher Site | Google Scholar
M. S. Davey, C. R. Willcox, A. T. Baker, S. Hunter, and B. E. Willcox, “Recasting Human Vδ1 lymphocytes in an adaptive role,” Trends in Immunology, vol. 39, no. 6, pp. 446–459, 2018.
View at: Publisher Site | Google Scholar
S. Hunter, C. R. Willcox, M. S. Davey et al., “Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations,” Journal of Hepatology, vol. 69, no. 3, pp. 654–665, 2018.
View at: Publisher Site | Google Scholar
M. S. Davey, C. R. Willcox, S. Hunter et al., “The human Vδ2⁺ T-cell compartment comprises distinct innate-like Vγ9⁺ and adaptive Vγ9^- subsets,” Nature Communications, vol. 9, no. 1, p. 1760, 2018.
View at: Publisher Site | Google Scholar
M. S. Davey, C. R. Willcox, S. P. Joyce et al., “Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR- dependent adaptive immune surveillance,” Nature Communications, vol. 8, no. 1, article 14760, 2017.
View at: Publisher Site | Google Scholar
S. Ravens, C. Schultze-Florey, S. Raha et al., “Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection,” Nature Immunology, vol. 18, no. 4, pp. 393–401, 2017.
View at: Publisher Site | Google Scholar
M. Kadivar, J. Petersson, L. Svensson, and J. Marsal, “CD8αβ⁺γδ T cells: a novel T cell subset with a potential role in inflammatory bowel disease,” The Journal of Immunology, vol. 197, no. 12, pp. 4584–4592, 2016.
View at: Publisher Site | Google Scholar
A. Gaballa, A. Stikvoort, B. Önfelt et al., “T-cell frequencies of CD8⁺γδ and CD27⁺γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation,” Bone Marrow Transplantation, vol. 54, no. 10, pp. 1562–1574, 2019.
View at: Publisher Site | Google Scholar
S. Berglund, A. Gaballa, P. Sawaisorn, B. Sundberg, and M. Uhlin, “Expansion of gammadelta T cells from cord blood: a therapeutical possibility,” Stem Cells International, vol. 2018, Article ID 8529104, 15 pages, 2018.
View at: Publisher Site | Google Scholar
A. Stikvoort, A. Gaballa, M. Solders et al., “Risk factors for severe acute graft-versus-host disease in donor graft composition,” Biology of Blood and Marrow Transplantation, vol. 24, no. 3, pp. 467–477, 2018.
View at: Publisher Site | Google Scholar
L. C. M. Arruda, A. Gaballa, and M. Uhlin, “Graft γδ TCR sequencing identifies public clonotypes associated with hematopoietic stem cell transplantation efficacy in acute myeloid leukemia patients and unravels cytomegalovirus impact on repertoire distribution,” Journal of Immunology, vol. 202, no. 6, pp. 1859–1870, 2019.
View at: Publisher Site | Google Scholar
T. Dimova, M. Brouwer, F. Gosselin et al., “Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 6, pp. E556–E565, 2015.
View at: Publisher Site | Google Scholar
D. Vermijlen, M. Brouwer, C. Donner et al., “Human cytomegalovirus elicits fetal γδ T cell responses in utero,” The Journal of Experimental Medicine, vol. 207, no. 4, pp. 807–821, 2010.
View at: Publisher Site | Google Scholar
M. S. Davey, C. R. Willcox, S. Hunter, Y. H. Oo, and B. E. Willcox, “Vδ2⁺ T cells—two subsets for the price of one,” Frontiers in Immunology, vol. 9, p. 2106, 2018.
View at: Publisher Site | Google Scholar
K. Deusch, F. Luling, K. Reich, M. Classen, H. Wagner, and K. Pfeffer, “A major fraction of human intraepithelial lymphocytes simultaneously expresses the γ/δ T cell receptor, the CD8 accessory molecule and preferentially uses the V_δ1 gene segment,” European Journal of Immunology, vol. 21, no. 4, pp. 1053–1059, 1991.
View at: Publisher Site | Google Scholar
C. T. Morita, S. Verma, P. Aparicio, C. Martinez-A, H. Spits, and M. B. Brenner, “Functionally distinct subsets of human γ/δ T cells,” European Journal of Immunology, vol. 21, no. 12, pp. 2999–3007, 1991.
View at: Publisher Site | Google Scholar
W. Scheper, S. van Dorp, S. Kersting et al., “γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia,” Leukemia, vol. 27, no. 6, pp. 1328–1338, 2013.
View at: Publisher Site | Google Scholar
N. Cantoni, H. H. Hirsch, N. Khanna et al., “Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease,” Biology of Blood and Marrow Transplantation, vol. 16, no. 9, pp. 1309–1314, 2010.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2019 Ahmed Gaballa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

2123

Downloads

1247

Citations

Stem Cells International

Infections in Hematopoietic Stem Cell Transplant

CD8+γδ T Cells Are More Frequent in CMV Seropositive Bone Marrow Grafts and Display Phenotype of an Adaptive Immune Response

Abstract

1. Introduction

2. Subjects and Methods

2.1. Donor Characteristics and Ethical Approval

2.2. Sample Preparation

2.3. Multicolor Flow Cytometry

2.4. γδ Genomic DNA Extraction and Immunosequencing

2.5. TCR γδ CDR3 Spectratyping

2.6. T Cell Culture and Proliferation Assays

2.7. Bioinformatics and Statistics

3. Results

3.1. Characterization of γδ T Cell Subsets in BM Grafts

3.2. Vγ9- Subsets within CMV+ Grafts Are Differentiated towards a Terminal Effector Phenotype

3.3. CD8+γδ T Cells within CMV+ BM Grafts Express Vγ9- and Preferentially Display Effector Phenotype

3.4. γδ TRG Repertoire is Clonally Focused in CMV+ Grafts

3.5. TCR/CD3 Stimulation Triggers CD8+γδ T Cells

3.6. γδ T Cell Proliferation in response to Cytokine Stimulation

4. Discussion

Data Availability

Conflicts of Interest

Authors’ Contributions

Acknowledgments

Supplementary Materials

References

Copyright

CD8⁺γδ T Cells Are More Frequent in CMV Seropositive Bone Marrow Grafts and Display Phenotype of an Adaptive Immune Response

3.2. Vγ9^- Subsets within CMV+ Grafts Are Differentiated towards a Terminal Effector Phenotype

3.3. CD8⁺γδ T Cells within CMV+ BM Grafts Express Vγ9^- and Preferentially Display Effector Phenotype

3.5. TCR/CD3 Stimulation Triggers CD8⁺γδ T Cells